fashion -WSS

fashion

author：entertainment 2025-09-03 09:38:20 - browse：41

A few years ago, Vijay Pande, then a professor at Stanford who was using computer science to understand biology, was deciding whether to leave full-time academic work to become a venture capitalist. He turned to Andrew Ng, another Stanford professor who had joined Google Brain and later the Chinese search firm Baidu.

“The things that we dreamed about five or 10 years ago were happening now,” Pande recalled Ng telling him. “The question was, do you want to be a part of it? Or do you want to write another paper?”

Pande decided to become a venture capitalist. The result, he told an audience at a STAT event in San Francisco last week, is that, whereas he managed about $1 million to $2 million in research as a top academic, he now works at the fabled Silicon Valley firm Andreessen Horowitz, which invests $100 million a year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Hottest summer in 2,000 years puts focus on extreme heat, health

focus

WSS

Abbott's new stent may help patients with peripheral artery disease

'Vaccine

Laying a path for careers in science

Hottest summer in 2,000 years puts focus on extreme heat, health

Readout Newsletter: Beam, Prozac, "TechBio" and more

Change Healthcare cyberattack shows risk of industry consolidation

knowledge

fashion

knowledge

In age of alternative facts, a scholarly course on calling out crap

Ohio train derailment: Experts on toxic chemical risks

Novavax promises a turnaround & Lilly roils the obesity market

Free medical tuition alone isn't enough to close gaps in primary care

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Beam, Prozac, "TechBio" and more

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

knowledge

Medicare isn't yet testing food as medicine

WuXi Biologics beefs up its lobbying operation

Laying a path for careers in science

Change Healthcare cyberattack shows risk of industry consolidation

Abbott's new stent may help patients with peripheral artery disease

STAT series 'Denied by AI' wins major journalism prizes

hotspot

focus

focus

hotspot